PSTV vs. ARCC
Compare and contrast key facts about Plus Therapeutics Inc (PSTV) and Ares Capital Corporation (ARCC).
Performance
PSTV vs. ARCC - Performance Comparison
Loading graphics...
PSTV vs. ARCC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PSTV Plus Therapeutics Inc | -68.26% | -55.45% | -34.29% | -63.19% | -69.81% | -48.02% | -15.83% | -83.45% | -90.33% | -80.13% |
ARCC Ares Capital Corporation | -8.49% | 1.07% | 19.78% | 20.03% | -3.84% | 36.14% | 0.86% | 31.30% | 8.81% | 4.50% |
Fundamentals
PSTV:
$12.65B
ARCC:
$12.60B
PSTV:
-$0.00
ARCC:
$1.64
PSTV:
3.17K
ARCC:
0.88
PSTV:
$0.00
ARCC:
$1.88B
PSTV:
$0.00
ARCC:
$1.18B
PSTV:
$0.00
ARCC:
$1.08B
Returns By Period
In the year-to-date period, PSTV achieves a -68.26% return, which is significantly lower than ARCC's -8.49% return. Over the past 10 years, PSTV has underperformed ARCC with an annualized return of -69.69%, while ARCC has yielded a comparatively higher 11.92% annualized return.
PSTV
- 1D
- -24.23%
- 1M
- -46.28%
- YTD
- -68.26%
- 6M
- -76.22%
- 1Y
- -82.89%
- 3Y*
- -66.56%
- 5Y*
- -66.21%
- 10Y*
- -69.69%
ARCC
- 1D
- 1.58%
- 1M
- -0.58%
- YTD
- -8.49%
- 6M
- -7.16%
- 1Y
- -10.69%
- 3Y*
- 9.35%
- 5Y*
- 8.75%
- 10Y*
- 11.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSTV vs. ARCC — Risk / Return Rank
PSTV
ARCC
PSTV vs. ARCC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Plus Therapeutics Inc (PSTV) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSTV | ARCC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.51 | -0.46 | -0.05 |
Sortino ratioReturn per unit of downside risk | -0.48 | -0.51 | +0.03 |
Omega ratioGain probability vs. loss probability | 0.94 | 0.93 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | -1.02 | -0.54 | -0.48 |
Martin ratioReturn relative to average drawdown | -1.55 | -1.12 | -0.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PSTV | ARCC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.51 | -0.46 | -0.05 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.34 | 0.44 | -0.78 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.38 | 0.47 | -0.85 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.35 | 0.37 | -0.72 |
Correlation
The correlation between PSTV and ARCC is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PSTV vs. ARCC - Dividend Comparison
PSTV has not paid dividends to shareholders, while ARCC's dividend yield for the trailing twelve months is around 10.65%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSTV Plus Therapeutics Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARCC Ares Capital Corporation | 10.65% | 9.49% | 8.77% | 9.59% | 10.12% | 7.65% | 9.47% | 9.01% | 9.88% | 9.67% | 9.22% | 11.02% |
Drawdowns
PSTV vs. ARCC - Drawdown Comparison
The maximum PSTV drawdown since its inception was -100.00%, which is greater than ARCC's maximum drawdown of -79.36%. Use the drawdown chart below to compare losses from any high point for PSTV and ARCC.
Loading graphics...
Drawdown Indicators
| PSTV | ARCC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -79.36% | -20.64% |
Max Drawdown (1Y)Largest decline over 1 year | -84.06% | -19.35% | -64.71% |
Max Drawdown (5Y)Largest decline over 5 years | -99.62% | -21.76% | -77.86% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -56.77% | -43.23% |
Current DrawdownCurrent decline from peak | -100.00% | -16.71% | -83.29% |
Average DrawdownAverage peak-to-trough decline | -79.35% | -9.07% | -70.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.56% | 9.33% | +46.23% |
Volatility
PSTV vs. ARCC - Volatility Comparison
Plus Therapeutics Inc (PSTV) has a higher volatility of 34.29% compared to Ares Capital Corporation (ARCC) at 6.61%. This indicates that PSTV's price experiences larger fluctuations and is considered to be riskier than ARCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PSTV | ARCC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 34.29% | 6.61% | +27.68% |
Volatility (6M)Calculated over the trailing 6-month period | 83.69% | 15.16% | +68.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 164.00% | 23.48% | +140.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 197.12% | 19.88% | +177.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 184.35% | 25.53% | +158.82% |
Financials
PSTV vs. ARCC - Financials Comparison
This section allows you to compare key financial metrics between Plus Therapeutics Inc and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities